HOME >> MEDICINE >> NEWS
Effectiveness of drugs used to treat Parkinson's disease in early, later stages measured

DENVER, CO The use of different medications during early versus later stages of Parkinsons disease is critical to managing symptoms and perhaps the progression of the disease, according to a study presented at the Annual Meeting of the American Academy of Neurology.

The main pathologic and biochemical characteristic of Parkinsons disease is the selective cell death of dopaminergic neurons in the midbrain area called substantia nigra and marked decrease in dopamine neurotransmitter produced by these neurons.

In a study conducted by the Parkinson Study Group and led by investigators at the Institute for Neurodegenerative Disorders in New Haven, Conn., the rate of this dopaminergic degeneration after early treatment with the drugs pramipexole and levodopa, administered to 82 early Parkinsons patients, was compared using brain imaging.

Our data suggest that patients initially treated with pramipexole experience a significantly slower rate of loss of dopaminergic neuronal functioning compared to those treated with levodopa, said study author Kenneth Marek, MD. While there remains debate about treatment for early Parkinsons disease -- and all treatment should be individualized to meet the needs of the patient this study adds important new information to the growing body of knowledge on the early treatment of Parkinsons disease.

Ultimately, most patients will be treated with both levodopa and a dopamine agonist, Marek said.

Marek cautions that further, long-term study comparing the clinical endpoints of these drug therapies relative to Parkinsons progression will be required to assess the clinical impact of these imaging findings.


'"/>

Contact: Cheryl Alementi
calementi@aan.com
651-695-2737
American Academy of Neurology
16-Apr-2002


Page: 1

Related medicine news :

1. Effectiveness of safer smallpox vaccine demonstrated against monkeypox
2. Effectiveness of chickenpox vaccine decreases after one year
3. University Of Pittsburgh Cancer Institute Defines First Immunologic Markers Of Interferon Effectiveness Against Melanoma
4. Interleukin-2 Boosts Cancer Vaccine Effectiveness In Mice
5. Discovery May Boost Effectiveness Of Chemotherapy
6. National Clinical Trial To Test Effectiveness Of Antibiotic Treatment For Coronary Artery Disease
7. Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs
8. Study Pinpoints Effectiveness Of Prostate Cancer Therapies To Patient Populations
9. Four-Year Study Shows Long-Term Effectiveness Of Proscar In Treating Enlarged Prostates
10. Researchers Finding May Boost Effectiveness Of Anti-HIV Drugs
11. Scientists Track Effectiveness Of Migraine Drugs With Ultrasound

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
Breaking Medicine Technology:
Cached News: